4D Molecular Therapeutics (FDMT) Amortizatization of Intangibles (2021 - 2026)

4D Molecular Therapeutics (FDMT) has 6 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 10.5% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 40.18% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 34.09% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $1.1 million, down from $1.1 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for FDMT reached as high as $2.3 million in Q2 2024 and fell as low as -$582000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $778529.4 across 5 years, with a median of $757000.0 in 2024.
• Across the five-year window, Amortizatization of Intangibles jumped 1393.33% in 2024 and sank 50.06% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $231000.0 in 2022, then surged by 107.36% to $479000.0 in 2023, then jumped by 286.22% to $1.8 million in 2024, then sank by 38.0% to $1.1 million in 2025, then declined by 1.13% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.